Comparative Proteomics Analysis of Exosomes Identifies Key Pathways and Protein Markers Related to Breast Cancer Metastasis
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24044033 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Shichen Shen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University at Buffalo, Buffalo, NY 14214, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Exosomes, Biomarkers, Tumor. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Roswell Park Cancer Institute and National Cancer Institute (NCI), Roswell Park Alliance Foundation, and NCI.
Abstract (Originalsprache)
Proteomics analysis of circulating exosomes derived from cancer cells represents a promising approach to the elucidation of cell–cell communication and the discovery of putative biomarker candidates for cancer diagnosis and treatment. Nonetheless, the proteome of exosomes derived from cell lines with different metastatic capabilities still warrants further investigation. Here, we present a comprehensive quantitative proteomics investigation of exosomes isolated from immortalized mammary epithelial cells and matched tumor lines with different metastatic potentials in an attempt to discover exosome markers specific to breast cancer (BC) metastasis. A total of 2135 unique proteins were quantified with a high confidence level from 20 isolated exosome samples, including 94 of the TOP 100 exosome markers archived by ExoCarta. Moreover, 348 altered proteins were observed, among which several metastasis-specific markers, including cathepsin W (CATW), magnesium transporter MRS2 (MRS2), syntenin-2 (SDCB2), reticulon-4 (RTN), and UV excision repair protein RAD23 homolog (RAD23B), were also identified. Notably, the abundance of these metastasis-specific markers corresponds well with the overall survival of BC patients in clinical settings. Together, these data provide a valuable dataset for BC exosome proteomics investigation and prominently facilitate the elucidation of the molecular mechanisms underlying primary tumor development and progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, University at Buffalo, Buffalo, NY 14214, USA.
- New York State Center of Excellence in Bioinformatics and Life Sciences, Buffalo, NY 14203, USA.
- Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
- Department of Molecular and Cellular Biology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
ORCID-Profile: Jianmin Zhang, Jun Qu
Förderung
- NCI NIH HHS
- Roswell Park Cancer Institute and National Cancer Institute (NCI)
- Roswell Park Alliance Foundation, and NCI
Zitieren
APA
Shen, S., Tu, C., Shen, H., Li, J., Frangou, C., Zhang, J., & Qu, J. (2023). Comparative Proteomics Analysis of Exosomes Identifies Key Pathways and Protein Markers Related to Breast Cancer Metastasis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24044033
Vancouver
Shen S, Tu C, Shen H, Li J, Frangou C, Zhang J, et al. Comparative Proteomics Analysis of Exosomes Identifies Key Pathways and Protein Markers Related to Breast Cancer Metastasis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24044033
BibTeX
@article{Shen2023,
author = {Shen, Shichen and Tu, Chengjian and Shen, He and Li, Jun and Frangou, Costa and Zhang, Jianmin and Qu, Jun},
title = {Comparative Proteomics Analysis of Exosomes Identifies Key Pathways and Protein Markers Related to Breast Cancer Metastasis},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24044033}
}
EUVIMED